Compare STZ & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STZ | STE |
|---|---|---|
| Founded | 1945 | 1985 |
| Country | United States | United States |
| Employees | N/A | 3700 |
| Industry | Beverages (Production/Distribution) | Industrial Specialties |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.6B | 21.6B |
| IPO Year | 1994 | 2018 |
| Metric | STZ | STE |
|---|---|---|
| Price | $132.52 | $231.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 5 |
| Target Price | $175.63 | ★ $275.20 |
| AVG Volume (30 Days) | ★ 1.8M | 711.0K |
| Earning Date | 04-08-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.74% | 1.19% |
| EPS Growth | N/A | ★ 27.90 |
| EPS | N/A | ★ 7.93 |
| Revenue | ★ $9,139,000,000.00 | $5,935,900,000.00 |
| Revenue This Year | $0.73 | $9.88 |
| Revenue Next Year | $1.93 | $6.32 |
| P/E Ratio | ★ $24.93 | $29.35 |
| Revenue Growth | N/A | ★ 8.73 |
| 52 Week Low | $126.45 | $195.14 |
| 52 Week High | $174.32 | $269.44 |
| Indicator | STZ | STE |
|---|---|---|
| Relative Strength Index (RSI) | 46.91 | 51.17 |
| Support Level | $127.80 | $217.07 |
| Resistance Level | $135.09 | $223.08 |
| Average True Range (ATR) | 2.34 | 5.06 |
| MACD | 0.45 | 0.68 |
| Stochastic Oscillator | 56.17 | 49.71 |
Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the US, generating more than 90% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company has pruned assets in recent years. With its exclusive rights tied to the Mexican beer brands effective only in the US, the firm has limited revenue exposure to international markets. Constellation owns a 10% stake in Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.